Tesevatinib TQ0166
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Tesevatinib is an orally available, multi-target tyrosine kinase inhibitor (IC50s: 0.3, 16, 1.5, 8.7, and 1.4 nM for EGFR, ErbB2, KDR, Flt4, and EphB4).
CAS nr:
781613-23-8
Purity:
98%
Molecular Weight:
491,39
SMILES:
CN1C[C@H](CC(COc(cc(c2c3)ncnc2Nc(c(F)c2Cl)ccc2Cl)c3OC)C2)[C@H]2C1
Formula:
C24H25Cl2FN4O2
Pathway:
Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors,Tyrosine Kinase/Adaptors,Angiogenesis,JAK/STAT signaling
Target:
FLT,FLT,Ephrin Receptor,VEGFR,VEGFR,EGFR,EGFR,EGFR
